Several classes of medication can cause secondary hypertension, meaning high blood pressure that develops as a direct side effect of a drug rather than from an underlying disease. The most common culprits are NSAIDs, hormonal contraceptives, stimulants, certain antidepressants, immunosuppressive drugs, and some cancer therapies. In many cases, blood pressure returns to normal once the medication is stopped or swapped, making drug-induced hypertension one of the more reversible forms of secondary hypertension.
NSAIDs: The Most Common Culprit
Nonsteroidal anti-inflammatory drugs are the medication class most frequently linked to secondary hypertension, partly because they’re so widely used. Ibuprofen, naproxen, and prescription-strength versions all share the same mechanism: they block an enzyme involved in pain signaling, but that same enzyme plays a role in kidney function. Blocking it reduces blood flow to the kidneys, lowers the filtration rate, and causes the body to hold onto extra sodium and water. The result is higher blood volume and higher pressure against artery walls.
A meta-analysis found that NSAIDs as a group raised systolic blood pressure by about 5 mmHg. That may sound modest, but in people already being treated for high blood pressure, the effect can be much larger. Patients taking ACE inhibitors saw their 24-hour average blood pressure climb by roughly 12/5 mmHg when they added an NSAID. The interaction was smaller in people on diuretics or vasodilators, likely because those drugs counteract fluid retention more directly. If you take a blood pressure medication and use NSAIDs regularly for joint pain or headaches, this combination is worth discussing with your provider.
Hormonal Contraceptives
Combined oral contraceptives containing estrogen raise blood pressure in a significant number of users. Prospective studies estimate average increases of 7 to 17 mmHg systolic and 3 to 11 mmHg diastolic, with 4% to 18% of users developing clinical hypertension.
The mechanism centers on how estrogen interacts with the body’s main blood pressure regulation system: the renin-angiotensin-aldosterone system, or RAAS. Estrogen stimulates the liver to produce more angiotensinogen, a protein that kicks off a hormonal cascade ending in sodium retention, blood vessel constriction, and increased nervous system activity. In one study, angiotensinogen levels doubled in women taking higher-dose pills, while lower-dose formulations still produced a 12% to 20% increase.
What makes this tricky is that RAAS activation shows up in contraceptive users regardless of whether their blood pressure actually rises. Some researchers believe the difference lies in feedback: normally, the body senses the RAAS surge and dials back production of renin (the enzyme that starts the cascade). In women whose blood pressure does climb, that feedback loop appears to be impaired, so the system stays overactivated. Downstream kidney effects, including higher resistance to blood flow and lower overall renal circulation, have been confirmed in these users, and the changes reverse when RAAS-blocking agents are given.
Stimulants and Decongestants
Prescription stimulants used for ADHD, including amphetamine-based medications and methylphenidate, raise blood pressure through several pathways. They increase circulating catecholamines (your body’s “fight or flight” chemicals), which constrict blood vessels, speed up heart rate, and directly elevate pressure. For most people, the increase is small and clinically manageable, but it can become significant in someone with preexisting hypertension or cardiovascular risk.
Over-the-counter decongestants like pseudoephedrine work through a similar sympathomimetic mechanism: they narrow blood vessels in the nasal passages to relieve congestion, but that narrowing isn’t limited to the nose. Systemic vasoconstriction raises blood pressure, which is why decongestant packaging warns against use in people with high blood pressure. The effect is temporary but can be pronounced, especially with repeated dosing during cold and allergy season.
Certain Antidepressants
Among antidepressants, one subclass stands out for blood pressure effects: serotonin-norepinephrine reuptake inhibitors, or SNRIs. Venlafaxine is the most studied example. At lower doses, venlafaxine primarily affects serotonin. But once the daily dose exceeds about 150 mg, its norepinephrine-boosting effects become more prominent. Norepinephrine constricts blood vessels and raises heart rate, the same “fight or flight” chemistry that makes stimulants problematic.
Clinically apparent blood pressure increases are most commonly reported at doses above 300 mg per day, but case reports document hypertension developing at 150 mg daily, particularly in people whose blood pressure was already on the higher end of normal before starting treatment. The onset can be rapid, sometimes within a week of a dose increase. Other SNRIs like duloxetine carry a similar theoretical risk, though the evidence is strongest for venlafaxine.
Immunosuppressive Drugs
Calcineurin inhibitors, a class of immunosuppressive drugs given to organ transplant recipients to prevent rejection, are well-known causes of secondary hypertension. These medications constrict the small blood vessels in the kidneys, reduce the kidney’s ability to excrete sodium, and may also increase activity in the sympathetic nervous system.
Among the two most commonly used calcineurin inhibitors, cyclosporine produces significantly higher rates of hypertension than tacrolimus. In liver transplant recipients, the difference is statistically significant, with cyclosporine-treated patients developing high blood pressure more often than those on tacrolimus or newer alternatives like everolimus. Because transplant patients typically cannot simply stop these medications, their hypertension often requires treatment with blood pressure drugs rather than discontinuation of the offending agent.
Cancer Therapies Targeting Blood Vessel Growth
A newer and increasingly important category involves cancer drugs that block VEGF signaling, a pathway tumors use to grow new blood vessels. These therapies cause hypertension in 30% to 80% of patients, one of the highest rates of any medication class.
The mechanism is straightforward: VEGF normally stimulates the inner lining of blood vessels to produce nitric oxide, a molecule that keeps vessels relaxed and dilated. When VEGF is blocked, nitric oxide production drops, vessels constrict, and blood pressure rises. Over time, chronic VEGF inhibition also causes capillary rarefaction, a reduction in the total number of tiny blood vessels, which further increases resistance to blood flow. Because these drugs are used in active cancer treatment, managing the hypertension with additional medication is generally preferred over stopping therapy.
Herbal Supplements and OTC Products
A number of herbal products can raise blood pressure, and they’re easy to overlook because people don’t always think of supplements as “medications.” A review of the literature identified at least 15 herbal products linked to hypertension, including licorice, ephedra, ginseng, guarana, bitter orange, yohimbine, St. John’s wort, ginkgo, and dong quai.
Licorice is one of the best-documented offenders. Its active compound mimics aldosterone, causing the kidneys to retain sodium and excrete potassium, which raises blood pressure. Ephedra and bitter orange contain stimulant compounds that constrict blood vessels. Guarana is essentially a concentrated caffeine source. These products are especially concerning because they may be combined in weight-loss or energy supplements, stacking multiple blood-pressure-raising mechanisms in a single pill.
How Quickly Blood Pressure Recovers
For most medication-induced hypertension, stopping or switching the drug is the primary fix. The timeline for recovery depends on the medication, how long you were taking it, and whether you had any underlying blood pressure elevation beforehand. Short-acting drugs like decongestants clear within hours to days. NSAIDs and contraceptives may take several weeks for blood pressure to fully normalize as kidney function and hormonal pathways readjust.
The picture is less straightforward for long-term medications. Research on blood pressure after drug withdrawal shows that about 40% of people remain below hypertension thresholds at one year after stopping, but that number drops to roughly 26% at two years or longer. This suggests that for some people, the medication may have been masking or accelerating an underlying tendency toward hypertension that persists even after the drug is gone. Monitoring blood pressure after discontinuation, rather than assuming the problem is solved, gives you the clearest picture of whether recovery is complete.